Cleared Traditional

BBL MGIT PRODUCTS (K954932) - FDA 510(k) Clearance

Class I Microbiology device.

K954932 · Becton Dickinson Diagnostic Instrument Systems · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1996
Decision
299d
Days
Class 1
Risk

K954932 is an FDA 510(k) clearance for the BBL MGIT PRODUCTS. Classified as System, Blood Culturing (product code MDB), Class I - General Controls.

Submitted by Becton Dickinson Diagnostic Instrument Systems (Sparks, US). The FDA issued a Cleared decision on August 21, 1996 after a review of 299 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2560 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Becton Dickinson Diagnostic Instrument Systems devices

Submission Details

510(k) Number K954932 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 1995
Decision Date August 21, 1996
Days to Decision 299 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
197d slower than avg
Panel avg: 102d · This submission: 299d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code MDB System, Blood Culturing
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.2560
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - MDB System, Blood Culturing

All 67
Devices cleared under the same product code (MDB) and FDA review panel - the closest regulatory comparables to K954932.
BD BACTEC FXI Culture System
K260213 · Bd Diagnostic Systems · May 2026
BD BACTEC™ Myco/F Lytic Culture Vials
K222559 · Becton, Dickinson and Company · Mar 2023
BD BACTEC™ Plus Aerobic/F Culture Vials
K222591 · Becton, Dickinson and Company · Mar 2023
BACT/ALERT MP Reagent System
K190405 · bioMerieux, Inc. · May 2019
BacT/ALERT FA Plus
K183166 · bioMerieux, Inc. · Feb 2019
BD BACTEC Peds Plus/F Culture Vials Soybean-Casein Digest Broth with Resins in a Plastic Vial
K173873 · Becton, Dickinson and Company · Mar 2018